Emerging Markets and Alternative Distributor Models
Multinational corporations constantly face an increasingly competitive global environment.
As commercial prospects diminish in developed markets – due to declining economic growth, regulatory challenges, pricing pressures and patent expirations – corporations are continuously reassessing their international strategies. One alternative path has been to selectively expand into what are referred to as "emerging markets."
These markets are not uniform, and each country needs to be reviewed on its own merits.
Corporate stakeholders with specific areas of expertise need to be consulted prior to market entry and during the early and crucial stages of operations to ensure strategies are being executed in a pragmatic manner.
Derek Kosti
![Consultant Derek Kosti](/cache/photos/ee39ac8b3a2ae5773a96c4f312c8f58b8061c70f-1509205388.png-290)
Skills and Expertise: What's this?
About Derek
- International finance professional with more than 20 years of experience in the pharmaceutical industry with a Fortune 100 Company
- Former finance lead for Asia, China, Indonesia, Eastern Europe and a newly established European business unit focusing on revenue growth, profitability improvement, expense rationalization, distribution strategies and restructuring
- Designed finance structures including a new international controller role with oversight for more than 100 markets and hubs specializing in US GAAP, compliance, restructuring, sales recognition, joint-ventures and business collaborations
- Formulated and executed international commercial strategies in conjunction with multiple stakeholders
- Currently an independent consultant working with clients on identifying commercial opportunities in international markets
- Fluent in Mandarin Chinese
Experience
- As an independent consultant, assists companies in identifying commercial opportunities and executing strategies in international markets.
- Provides support in areas such as contract negotiations, distribution models, operational due diligence, organizational design alternatives and risk mitigation.
- Designed the first international divisional controllers structure for Pfizer's biopharmaceutical businesses and led a team in Europe, Latin America, Africa/Middle East and Asia to ensure the integrity of US GAAP reporting for more than 100 regional hubs and markets, with cumulative annual revenues of about $20 billion.
- Identified strategies to mitigate financial and operational exposure to Pfizer by incorporating multiple factors in risk models.
- Imparted guidance to markets on accounting issues relating to collaboration arrangements, revenue recognition, sales deductions, legal provisions, joint-ventures and restructuring.
- Collaborated with consulting firms and internal teams to assess the financial impact of the future implementation of the new 'Revenue Recognition' and 'Leasing' accounting standards on Pfizer's global operations.
- As Senior Finance Director, led teams in Central-Southern Europe, Asia, and Northern Europe to achieve Enterprise financial and strategic objectives.
- Designed financial reporting processes and identified commercial opportunities for a newly established business unit focused on products that had lost exclusivity.
- Guided the Pfizer Russia Board of Directors.
- Executed operational and legal integrations in multiple international markets relating to the Warner-Lambert and Pharmacia acquisitions.
- Co-led China strategy that assessed distribution networks, legal structures and commercial strategies.
- Led the publicly-listed Pfizer Indonesia legal entity with annual revenues of about $20 million. Headed multifunctional task force to establish a marketing joint venture with a major Indonesian pharmaceutical company.
- Formulated a risk management system and enhanced internal controls by establishing policies & procedures for Pfizer’s joint-venture.
Education
Academic Awards
Academic ScholarshipAcademic Honors
Senior HonorsLicenses & Certifications
Panels
- 2017 Malaysia Midwest Games - Assessing the value of an overseas education
- CBI Conference (Philadelphia) - Implementing the new Revenue Recognition Standard
- Harvard Club; CFO Conference - Challenges faced by a CFO